Trade Summary

1 week ago, Aghazadeh Behzad, serving as See Remarks at Scribe Therapeutics, Inc. (SCTX), purchased 2,391,238 shares at $15.16 per share, for a total transaction value of $36,259,761.25. Following this transaction, Aghazadeh Behzad now holds 3,088,888 shares of SCTX.

This purchase represents a 342.76% increase in Aghazadeh Behzad's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, July 24, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 29, 2026 (accepted Jul 28, 9:30 PM ET), 5 days after the trade was made.

Scribe Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.